Travere Therapeutics, Inc. (TVTX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TVTX currently has 91.9M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 18.43% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 04, 2026 |
10-Q filing | 91.9M shares outstanding |
92M | 0 |
| May 01, 2025 |
10-Q filing | 88.4M shares outstanding |
88M | 0 |
| Feb 21, 2025 |
10-K filing | 88.7M shares outstanding |
89M | 0 |
| Oct 31, 2024 |
10-Q filing | 77.8M shares outstanding |
78M | 0 |
| Aug 01, 2024 |
10-Q filing | 77.5M shares outstanding |
78M | 0 |
| May 06, 2024 |
10-Q filing | 77.1M shares outstanding |
77M | 0 |
| Feb 20, 2024 |
10-K filing | 74.3M shares outstanding |
74M | 0 |
| Nov 07, 2023 |
10-Q filing | 76.3M shares outstanding |
76M | 0 |
| Aug 03, 2023 |
10-Q filing | 76.0M shares outstanding |
76M | 0 |
| May 04, 2023 |
10-Q filing | 68.2M shares outstanding |
68M | 0 |
| Feb 23, 2023 |
10-K filing | 63.8M shares outstanding |
64M | 0 |
| Oct 27, 2022 |
10-Q filing | 64.0M shares outstanding |
64M | 0 |
| Aug 04, 2022 |
10-Q filing | 63.6M shares outstanding |
64M | 0 |
| May 05, 2022 |
10-Q filing | 63.1M shares outstanding |
63M | 0 |
| Feb 24, 2022 |
10-K filing | 59.8M shares outstanding |
60M | 0 |
| Oct 29, 2021 |
10-Q filing | 60.8M shares outstanding |
61M | 0 |
| Jul 29, 2021 |
10-Q filing | 60.6M shares outstanding |
61M | 0 |
| May 06, 2021 |
10-Q filing | 56.3M shares outstanding |
56M | 0 |
| Mar 01, 2021 |
10-K filing | 60.2M shares outstanding |
60M | 0 |
| Nov 05, 2020 |
10-Q filing | 51.1M shares outstanding |
51M | 0 |
| Jul 31, 2020 |
10-Q filing | 50.9M shares outstanding |
51M | 0 |
| May 11, 2020 |
10-Q filing | 43.1M shares outstanding |
43M | 0 |
| Feb 24, 2020 |
10-K filing | 41.4M shares outstanding |
41M | 0 |